Robert Rossi, MD
Pain Medicine · Des Moines, IANPI 1518918317
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 46.2% of the total. Reporting peaked in 2020 at $2,860 and has fallen 92.3% since, to $222 in 2025.
Across 55 payments — averaging $77.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Boston Scientific$901
- Wardlow Enterprises$872
- Pfizer$165
- AbbVie$133
- Biotronik NRO, Inc.$111
- plus $104 from 5 others
What the payments were for
- Travel & lodging$68916%
- Food & beverage$1,62838%
- Education$1,93045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $1,960 |
| Boston Scientific | 22 | $901 |
| Wardlow Enterprises | 6 | $872 |
| Pfizer | 7 | $165 |
| AbbVie(2 entities) | 9 | $133 |
| Biotronik NRO, Inc. | 3 | $111 |
| Nevro Corp. | 1 | $35 |
| Abbott | 1 | $24 |
| Averitas Pharma Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,247 in reported general payments places this provider in the 65th percentile of 31 pain medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 16 | $340 |
| Methylprednisolone | 29 | $225 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Des Moines
- Daniel MoyseDes Moines$40K
- John RayburnDes Moines$6K
- Dana SimonDes Moines$143
- Garry ClarkSioux City$189K
- Jolene SmithClive$85K
- Christopher StalveyWest Des Moines$14K
- William ChangIowa City$9K
- Joysree SubramanianIowa City$9K
- John DooleyDavenport$6K
- Maruti KariBettendorf$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.